We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $59.6M
1-Year Est. Return 181.61%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+181.61%
3 Year Est. Return
+519.89%
5 Year Est. Return
+603.37%
10 Year Est. Return
+6,669.07%
AUM
$59.6M
AUM Growth
-$124M
Cap. Flow
-$135M
Cap. Flow %
-225.95%
Top 10 Hldgs %
65.41%
Holding
66
New
18
Increased
–
Reduced
2
Closed
43

Top Buys

Rank Stock Value
1
GOOGM
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
+$5.02M
2
GOOGN
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
+$5.01M
3
DLR icon
Digital Realty Trust
DLR
+$4.79M
4
SYRE icon
Spyre Therapeutics
SYRE
+$3.65M
5
SMCIP
Super Micro Computer Depositary Shares 7% Series A Preferred Stock
SMCIP
+$2.69M

Top Sells

Rank Stock Value
1
TERN
Terns Pharmaceuticals
TERN
+$15.8M
2
NEE.PRV
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
+$15.2M
3
MDLN
Medline Inc
MDLN
+$13.3M
4
NRG icon
NRG Energy
NRG
+$12.4M
5
FPS
Forgent Power Solutions
FPS
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 37.05%
2 Communication Services 24.14%
3 Miscellaneous 13.47%
4 Real Estate 10.53%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGM
1
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
$5.09M 8.54%
+100,000
New +$5.02M
GOOGN
2
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
$5.03M 8.44%
+100,000
New +$5.01M
SLDB icon
3
Solid Biosciences
SLDB
$1.1B
$5M 8.38%
500,000
-920,295
-65% -$6.98M
DLR icon
4
Digital Realty Trust
DLR
$69.9B
$4.49M 7.53%
+25,000
New +$4.79M
SYRE icon
5
Spyre Therapeutics
SYRE
$7.85B
$4.44M 7.45%
+50,000
New +$3.65M
ADT icon
6
ADT
ADT
$5.45B
$3.9M 6.55%
600,000
-100,000
-14% -$686K
TNGX icon
7
Tango Therapeutics
TNGX
$3.8B
$3.13M 5.25%
+100,000
New +$2.47M
SMCIP
8
Super Micro Computer Depositary Shares 7% Series A Preferred Stock
SMCIP
$5B
$2.6M 4.36%
+50,000
New +$2.69M
LEGN icon
9
Legend Biotech
LEGN
$4.19B
$2.47M 4.14%
+85,385
New +$2.3M
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.14T
$2.14M 3.6%
+6,000
New +$2.16M
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.1T
$2.12M 3.56%
+6,000
New +$2.14M
QURE icon
12
uniQure
QURE
$3.09B
$2.07M 3.48%
+45,000
New +$1.18M
INIO
13
INNIO N.V.
INIO
$15.6B
$1.88M 3.16%
+47,650
New +$1.7M
AKR icon
14
Acadia Realty Trust
AKR
$2.79B
$1.79M 3%
+85,385
New +$1.83M
PTRN
15
Pattern Group Inc
PTRN
$3.58B
$1.61M 2.71%
+64,039
New +$1.09M
MLTX icon
16
MoonLake Immunotherapeutics
MLTX
$1.28B
$1.46M 2.45%
+75,000
New +$1.36M
WHK
17
WhiteHawk Minerals Corp
WHK
$662M
$1.43M 2.39%
+51,232
New +$1.39M
TSHA icon
18
Taysha Gene Therapies
TSHA
$1.82B
$1.36M 2.29%
+200,000
New +$1.18M
IMA
19
ImageneBio Inc
IMA
$55.1M
$1.13M 1.9%
+192,344
New +$1.09M
KARD
20
Kardigan Inc
KARD
$1.95B
$1.02M 1.71%
+42,693
New +$987K
ACRS icon
21
Aclaris Therapeutics
ACRS
$908M
– –
-500,000
Closed -$1.88M
ASTS icon
22
AST SpaceMobile
ASTS
$18.7B
– –
-45,000
Closed -$3.73M
BBIO icon
23
BridgeBio Pharma
BBIO
$14.6B
– –
-67,139
Closed -$4.99M
CMPX icon
24
Compass Therapeutics
CMPX
$429M
– –
-258,865
Closed -$1.37M
COHR icon
25
Coherent
COHR
$55.2B
– –
-5,000
Closed -$1.19M
1
2 3

Similar funds

ICM
Irth Capital Management New York $59.9M AUM 24.87% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $59.9M AUM 0.03% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $59.2M AUM 51.07% 1-Year Est. Return
CPM
Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return
WWP
Wise Wealth Partners Phoenix, Arizona $58.8M AUM 18.05% 1-Year Est. Return
CZI
Chan Zuckerberg Initiative Redwood City, California $58.5M AUM 31.79% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $58.3M AUM 11.49% 1-Year Est. Return
GCS
Gordian Capital (Singapore) Singapore $58.2M AUM 99.93% 1-Year Est. Return

Monashee Investment Management's Q2 2026 Portfolio in Review

As of Q2 2026, Monashee Investment Management held 66 positions worth $59.6M, down 68% from $184M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Monashee Investment Management withdrew a net $135M in Q2 2026, closing 43 positions and reducing 2 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 49% a quarter earlier, followed by Communication Services and Miscellaneous.

Against the trend, Monashee Investment Management opened a new position in Alphabet Inc Depositary Shares Series A Preferred Stock worth $5.09M.

  • Monashee Investment Management's largest Q2 2026 buy was Alphabet Inc Depositary Shares Series A Preferred Stock: 100,000 shares worth $5.09M.
  • Monashee Investment Management's biggest Q2 2026 reduction was Solid Biosciences, cutting an estimated $6.98M.
  • Monashee Investment Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $15.8M.
  • Monashee Investment Management's ten largest holdings make up 65% of its $59.6M portfolio in Q2 2026.
  • Monashee Investment Management opened 18 new positions and closed 43 in Q2 2026.
  • Monashee Investment Management's portfolio value fell 68% quarter-over-quarter to $59.6M.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.